Literature DB >> 16598420

Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones.

Shilpa Puli1, James C K Lai, Alok Bhushan.   

Abstract

Glioblastoma multiforme is a primary brain tumor associated with extensive invasion into surrounding brain tissue. Matrix metalloproteinases (MMPs) and urokinase plasminogen activation (uPA) system are shown to be involved in tumor invasion as they help in degradation of extracellular matrix (ECM) proteins and thus assist in the movement of cells. MMP-2 and 9 were shown to be upregulated in gliomas, suggesting their involvement in invasion. Genistein and biochanin A are isoflavones commonly known as phytoestrogens and have some anticancer properties. We hypothesize that these two isoflavones can induce a lowering of tumor invasion by decreasing the activity of matrix degrading enzymes. In this study we investigated the effects of genistein and biochanin A on invasive activity of U87MG cells using the Calbiochem in vitro invasion assay system. Our results suggest that genistein and biochanin A induced a decrease in invasive activity of U87MG cells in a dose-related manner. Genistein also induced a decrease in EGF-stimulated invasion thereby implicating an involvement of EGF-mediated signaling in invasion. Our results also show that treatment of U87MG cells with the two isoflavones induced decreases in the enzymatic activity of MMP-9 and the protein levels of MT1-MMP and uPAR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598420     DOI: 10.1007/s11060-006-9126-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  56 in total

1.  Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.

Authors:  G Cox; J L Jones; K J O'Byrne
Journal:  Clin Cancer Res       Date:  2000-06       Impact factor: 12.531

2.  In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.

Authors:  S Mohanam; S K Chintala; Y Go; A Bhattacharya; B Venkaiah; D Boyd; Z L Gokaslan; R Sawaya; J S Rao
Journal:  Oncogene       Date:  1997-03-20       Impact factor: 9.867

3.  Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro.

Authors:  M Lund-Johansen; R Bjerkvig; P A Humphrey; S H Bigner; D D Bigner; O D Laerum
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

4.  Genistein, a specific inhibitor of tyrosine-specific protein kinases.

Authors:  T Akiyama; J Ishida; S Nakagawa; H Ogawara; S Watanabe; N Itoh; M Shibuya; Y Fukami
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

Review 5.  Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

Authors:  Pia Vihinen; Veli-Matti Kähäri
Journal:  Int J Cancer       Date:  2002-05-10       Impact factor: 7.396

6.  Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association.

Authors:  S M Ellerbroek; J M Halbleib; M Benavidez; J K Warmka; E V Wattenberg; M S Stack; L G Hudson
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

Review 7.  Biochemical targets of the isoflavone genistein in tumor cell lines.

Authors:  S Barnes; T G Peterson
Journal:  Proc Soc Exp Biol Med       Date:  1995-01

8.  Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.

Authors:  Sajani S Lakka; Christopher S Gondi; Niranjan Yanamandra; Dzung H Dinh; William C Olivero; Meena Gujrati; Jasti S Rao
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

9.  Matrix metalloproteinase-2 activation modulates glioma cell migration.

Authors:  E I Deryugina; M A Bourdon; G X Luo; R A Reisfeld; A Strongin
Journal:  J Cell Sci       Date:  1997-10       Impact factor: 5.285

10.  Inhibitory effects of biochanin A on mouse lung tumor induced by benzo(a)pyrene.

Authors:  Y S Lee; J S Seo; H T Chung; J J Jang
Journal:  J Korean Med Sci       Date:  1991-12       Impact factor: 2.153

View more
  20 in total

Review 1.  Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Authors:  V B Gencel; M M Benjamin; S N Bahou; R A Khalil
Journal:  Mini Rev Med Chem       Date:  2012-02       Impact factor: 3.862

2.  Effect of combination treatment of rapamycin and isoflavones on mTOR pathway in human glioblastoma (U87) cells.

Authors:  Shilpa Puli; Aditi Jain; James C K Lai; Alok Bhushan
Journal:  Neurochem Res       Date:  2010-02-23       Impact factor: 3.996

3.  Signaling pathways mediating manganese-induced toxicity in human glioblastoma cells (u87).

Authors:  Shilpa Puli; James C K Lai; Kristina L Edgley; Christopher K Daniels; Alok Bhushan
Journal:  Neurochem Res       Date:  2006-10-17       Impact factor: 3.996

4.  Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression.

Authors:  Rebecca L Farmer; Margaret M Biddle; Antoinette E Nibbs; Xiaoke Huang; Raymond C Bergan; Karl A Scheidt
Journal:  ACS Med Chem Lett       Date:  2010-11-11       Impact factor: 4.345

5.  Biochanin A inhibits breast cancer tumor growth in a murine xenograft model.

Authors:  Young Jin Moon; Beom Soo Shin; Guohua An; Marilyn E Morris
Journal:  Pharm Res       Date:  2008-05-03       Impact factor: 4.200

6.  Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.

Authors:  Lauren Bryan; Barbara S Paugh; Dmitri Kapitonov; Katarzyna M Wilczynska; Silvina M Alvarez; Sandeep K Singh; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

Review 7.  Inhibition of cancer cell invasion and metastasis by genistein.

Authors:  Janet M Pavese; Rebecca L Farmer; Raymond C Bergan
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

8.  Estrogen increases survival in an orthotopic model of glioblastoma.

Authors:  Tara A Barone; Justin W Gorski; Steven J Greenberg; Robert J Plunkett
Journal:  J Neurooncol       Date:  2009-05-05       Impact factor: 4.130

9.  RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.

Authors:  Padmaja Tummalapalli; Christopher S Gondi; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  Int J Oncol       Date:  2007-07       Impact factor: 5.650

10.  Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood-brain barrier and glioma cells.

Authors:  Jonas Bruun; Trine B Larsen; Rasmus I Jølck; Rasmus Eliasen; René Holm; Torben Gjetting; Thomas L Andresen
Journal:  Int J Nanomedicine       Date:  2015-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.